Fear of Cancer Progression: A Comparison between the Fear of Progression Questionnaire (FoP-Q-12) and the Concerns about Recurrence Questionnaire (CARQ-4)
As cancer patients often suffer from fear of cancer progression (FoP), valid screening for FoP is of high relevance. The aims of this study were to test psychometric properties of two FoP questionnaires, to determine their relationship to other anxiety-related constructs, and to analyze the impact o...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-02-01
|
| Series: | Healthcare |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9032/12/4/435 |
| _version_ | 1797298169643532288 |
|---|---|
| author | Andreas Hinz Thomas Schulte Anja Mehnert-Theuerkauf Diana Richter Annekathrin Sender Hannah Brock Michael Friedrich Susanne Briest |
| author_facet | Andreas Hinz Thomas Schulte Anja Mehnert-Theuerkauf Diana Richter Annekathrin Sender Hannah Brock Michael Friedrich Susanne Briest |
| author_sort | Andreas Hinz |
| collection | DOAJ |
| description | As cancer patients often suffer from fear of cancer progression (FoP), valid screening for FoP is of high relevance. The aims of this study were to test psychometric properties of two FoP questionnaires, to determine their relationship to other anxiety-related constructs, and to analyze the impact of sociodemographic and clinical factors on the FoP. Our sample consisted of <i>n</i> = 1733 patients with mixed cancer diagnoses. For measuring FoP, the Fear of Progression questionnaire (FoP-Q-12) and the Concerns About Cancer Recurrence Questionnaire (CARQ-4) were used. The mean scores of the FoP-Q-12 and the CARQ-4 were 30.0 ± 10.4 and 16.1 ± 10.8, respectively, indicating relatively high levels of FoP. Both questionnaires showed excellent internal consistency coefficients, α = 0.895 and α = 0.915, respectively. The correlation between the two FoP questionnaires was <i>r</i> = 0.72. Female patients reported more FoP than male patients (<i>d</i> = 0.84 and <i>d</i> = 0.54, respectively). There was a nonlinear age dependency of FoP, with an increase found in the age range from 18 to 50 years and a decrease in the older age range. Radiation, chemotherapy, and antibody therapy, but not surgery, lead to an increase in FoP. Both questionnaires show good psychometric properties and can be recommended for use in an oncological routine. Female patients and patients in the middle-age range deserve special attention from healthcare providers. |
| first_indexed | 2024-03-07T22:30:58Z |
| format | Article |
| id | doaj.art-cbfb0c19981049e38f920e02e3b4eb91 |
| institution | Directory Open Access Journal |
| issn | 2227-9032 |
| language | English |
| last_indexed | 2024-03-07T22:30:58Z |
| publishDate | 2024-02-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Healthcare |
| spelling | doaj.art-cbfb0c19981049e38f920e02e3b4eb912024-02-23T15:18:14ZengMDPI AGHealthcare2227-90322024-02-0112443510.3390/healthcare12040435Fear of Cancer Progression: A Comparison between the Fear of Progression Questionnaire (FoP-Q-12) and the Concerns about Recurrence Questionnaire (CARQ-4)Andreas Hinz0Thomas Schulte1Anja Mehnert-Theuerkauf2Diana Richter3Annekathrin Sender4Hannah Brock5Michael Friedrich6Susanne Briest7Department of Medical Psychology and Medical Sociology, Comprehensive Cancer Center Central Germany, University Medical Center Leipzig, 04103 Leipzig, GermanyRehabilitation Clinic Bad Oexen, 32549 Bad Oeynhausen, GermanyDepartment of Medical Psychology and Medical Sociology, Comprehensive Cancer Center Central Germany, University Medical Center Leipzig, 04103 Leipzig, GermanyDepartment of Medical Psychology and Medical Sociology, Comprehensive Cancer Center Central Germany, University Medical Center Leipzig, 04103 Leipzig, GermanyDepartment of Medical Psychology and Medical Sociology, Comprehensive Cancer Center Central Germany, University Medical Center Leipzig, 04103 Leipzig, GermanyDepartment of Medical Psychology and Medical Sociology, Comprehensive Cancer Center Central Germany, University Medical Center Leipzig, 04103 Leipzig, GermanyDepartment of Medical Psychology and Medical Sociology, Comprehensive Cancer Center Central Germany, University Medical Center Leipzig, 04103 Leipzig, GermanyDepartment of Gynecology, Comprehensive Cancer Center Central Germany, University Medical Center Leipzig, 04103 Leipzig, GermanyAs cancer patients often suffer from fear of cancer progression (FoP), valid screening for FoP is of high relevance. The aims of this study were to test psychometric properties of two FoP questionnaires, to determine their relationship to other anxiety-related constructs, and to analyze the impact of sociodemographic and clinical factors on the FoP. Our sample consisted of <i>n</i> = 1733 patients with mixed cancer diagnoses. For measuring FoP, the Fear of Progression questionnaire (FoP-Q-12) and the Concerns About Cancer Recurrence Questionnaire (CARQ-4) were used. The mean scores of the FoP-Q-12 and the CARQ-4 were 30.0 ± 10.4 and 16.1 ± 10.8, respectively, indicating relatively high levels of FoP. Both questionnaires showed excellent internal consistency coefficients, α = 0.895 and α = 0.915, respectively. The correlation between the two FoP questionnaires was <i>r</i> = 0.72. Female patients reported more FoP than male patients (<i>d</i> = 0.84 and <i>d</i> = 0.54, respectively). There was a nonlinear age dependency of FoP, with an increase found in the age range from 18 to 50 years and a decrease in the older age range. Radiation, chemotherapy, and antibody therapy, but not surgery, lead to an increase in FoP. Both questionnaires show good psychometric properties and can be recommended for use in an oncological routine. Female patients and patients in the middle-age range deserve special attention from healthcare providers.https://www.mdpi.com/2227-9032/12/4/435fear of progressionfear of cancer recurrencehealth anxietypsycho-oncologycancerpsychometrics |
| spellingShingle | Andreas Hinz Thomas Schulte Anja Mehnert-Theuerkauf Diana Richter Annekathrin Sender Hannah Brock Michael Friedrich Susanne Briest Fear of Cancer Progression: A Comparison between the Fear of Progression Questionnaire (FoP-Q-12) and the Concerns about Recurrence Questionnaire (CARQ-4) Healthcare fear of progression fear of cancer recurrence health anxiety psycho-oncology cancer psychometrics |
| title | Fear of Cancer Progression: A Comparison between the Fear of Progression Questionnaire (FoP-Q-12) and the Concerns about Recurrence Questionnaire (CARQ-4) |
| title_full | Fear of Cancer Progression: A Comparison between the Fear of Progression Questionnaire (FoP-Q-12) and the Concerns about Recurrence Questionnaire (CARQ-4) |
| title_fullStr | Fear of Cancer Progression: A Comparison between the Fear of Progression Questionnaire (FoP-Q-12) and the Concerns about Recurrence Questionnaire (CARQ-4) |
| title_full_unstemmed | Fear of Cancer Progression: A Comparison between the Fear of Progression Questionnaire (FoP-Q-12) and the Concerns about Recurrence Questionnaire (CARQ-4) |
| title_short | Fear of Cancer Progression: A Comparison between the Fear of Progression Questionnaire (FoP-Q-12) and the Concerns about Recurrence Questionnaire (CARQ-4) |
| title_sort | fear of cancer progression a comparison between the fear of progression questionnaire fop q 12 and the concerns about recurrence questionnaire carq 4 |
| topic | fear of progression fear of cancer recurrence health anxiety psycho-oncology cancer psychometrics |
| url | https://www.mdpi.com/2227-9032/12/4/435 |
| work_keys_str_mv | AT andreashinz fearofcancerprogressionacomparisonbetweenthefearofprogressionquestionnairefopq12andtheconcernsaboutrecurrencequestionnairecarq4 AT thomasschulte fearofcancerprogressionacomparisonbetweenthefearofprogressionquestionnairefopq12andtheconcernsaboutrecurrencequestionnairecarq4 AT anjamehnerttheuerkauf fearofcancerprogressionacomparisonbetweenthefearofprogressionquestionnairefopq12andtheconcernsaboutrecurrencequestionnairecarq4 AT dianarichter fearofcancerprogressionacomparisonbetweenthefearofprogressionquestionnairefopq12andtheconcernsaboutrecurrencequestionnairecarq4 AT annekathrinsender fearofcancerprogressionacomparisonbetweenthefearofprogressionquestionnairefopq12andtheconcernsaboutrecurrencequestionnairecarq4 AT hannahbrock fearofcancerprogressionacomparisonbetweenthefearofprogressionquestionnairefopq12andtheconcernsaboutrecurrencequestionnairecarq4 AT michaelfriedrich fearofcancerprogressionacomparisonbetweenthefearofprogressionquestionnairefopq12andtheconcernsaboutrecurrencequestionnairecarq4 AT susannebriest fearofcancerprogressionacomparisonbetweenthefearofprogressionquestionnairefopq12andtheconcernsaboutrecurrencequestionnairecarq4 |